Cargando…
Epigenetic dysregulation of NKD2 is a valuable predictor assessing treatment outcome in acute myeloid leukemia
AIM: The present study was aimed to investigate NKD2 expression as well as promoter methylation and further analyze their clinical significance in patients with acute myeloid leukemia (AML). METHODS: Real-time quantitative PCR was carried out to detect the pattern of NKD2 expression in 113 AML patie...
Autores principales: | Li, Xi-xi, Zhou, Jing-dong, Zhang, Ting-juan, Yang, Lei, Wen, Xiang-mei, Ma, Ji-chun, Yang, Jing, Zhang, Zhi-hui, Lin, Jiang, Qian, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332898/ https://www.ncbi.nlm.nih.gov/pubmed/28261348 http://dx.doi.org/10.7150/jca.16914 |
Ejemplares similares
-
Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies
por: Zhou, Jing‐dong, et al.
Publicado: (2017) -
Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma
por: Li, Lijun, et al.
Publicado: (2023) -
Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2018) -
MicroRNA-335/ID4 dysregulation predicts clinical outcome and facilitates leukemogenesis by activating PI3K/Akt signaling pathway in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2019) -
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth
por: Dong, Yan, et al.
Publicado: (2015)